Vivos Therapeutics (VVOS) Income from Non-Controlling Interests (2026)
Vivos Therapeutics (VVOS) reported Income from Non-Controlling Interests of -$69000.0 for Q1 2026.
Vivos Therapeutics (VVOS) Income from Non-Controlling Interests (2026) Analysis & Trends
Vivos Therapeutics (VVOS) has 1 years of Income from Non-Controlling Interests data on file, last reported at -$69000.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | - |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | - |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 6.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 22.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -5.85 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 100,000.00 |
| 10 | Vivos Therapeutics | 8.16 Mn | 5.93 Mn | 3.06 Mn | -69,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -69,000.00 |